Literature DB >> 19699193

Characterisation of circulating DNA by parallel tagged sequencing on the 454 platform.

Maniesh van der Vaart1, Dmitry V Semenov, Elena V Kuligina, Vladimir A Richter, Piet J Pretorius.   

Abstract

BACKGROUND: Fragments of genomic DNA that can be isolated from the blood and body fluids of vertebrates are also known as circulating DNA. This DNA has widely been investigated as a biomarker for cancer and other diseases but the origin and significance of circulating DNA have not been elucidated to date.
METHODS: We used a parallel tagged sequencing method to sequence circulating DNA obtained from control individuals as well as cancer patients on the GSFLX sequencer (454 life sciences).
RESULTS: Circulating DNA sequenced on one 16th of a picotiter plate produced approximately 3600 unique circulating DNA sequences which were distributed over the human genome and a higher frequency of mutations was observed in cancer patients compared to healthy controls.
CONCLUSION: Circulating DNA represents genomic DNA in the blood of an individual, some sequence related differences might be evident between circulating DNA from cancer individuals and controls but distribution over the genome is similar.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19699193     DOI: 10.1016/j.cca.2009.08.011

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  9 in total

1.  Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients.

Authors:  Peiyong Jiang; Carol W M Chan; K C Allen Chan; Suk Hang Cheng; John Wong; Vincent Wai-Sun Wong; Grace L H Wong; Stephen L Chan; Tony S K Mok; Henry L Y Chan; Paul B S Lai; Rossa W K Chiu; Y M Dennis Lo
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-02       Impact factor: 11.205

2.  Current status and future potential of somatic mutation testing from circulating free DNA in patients with solid tumours.

Authors:  K L Aung; R E Board; G Ellison; E Donald; T Ward; G Clack; M Ranson; A Hughes; W Newman; C Dive
Journal:  Hugo J       Date:  2011-01-30

Review 3.  The Utility of Repetitive Cell-Free DNA in Cancer Liquid Biopsies.

Authors:  Ugur Gezer; Abel J Bronkhorst; Stefan Holdenrieder
Journal:  Diagnostics (Basel)       Date:  2022-06-01

4.  Characterization of H3K9me3- and H4K20me3-associated circulating nucleosomal DNA by high-throughput sequencing in colorectal cancer.

Authors:  Ugur Gezer; Duran Ustek; Ebru E Yörüker; Aris Cakiris; Neslihan Abaci; Gloria Leszinski; Nejat Dalay; Stefan Holdenrieder
Journal:  Tumour Biol       Date:  2012-10-20

5.  Design of a liver cancer-specific selector for the analysis of circulating tumor DNA.

Authors:  Yan Sun; Rui Meng; Heng Tang; Huimin Wang; Xueqin Guo; Yuanyuan Ma; Yun Yang; Xiaoming Wei; Feng Mu; Gang Wu; Jun Wang; Jun Liu; Mingshan Niu; Jun Xue
Journal:  Oncol Lett       Date:  2019-04-12       Impact factor: 2.967

Review 6.  The Prospect and Challenges to the Flow of Liquid Biopsy in Africa.

Authors:  Dada Oluwaseyi Temilola; Martha Wium; Tangbadioa Herve Coulidiati; Henry Ademola Adeola; Giuseppina Maria Carbone; Carlo Vittorio Catapano; Luiz Fernando Zerbini
Journal:  Cells       Date:  2019-08-09       Impact factor: 6.600

Review 7.  Role of Cell-Free DNA and Deoxyribonucleases in Tumor Progression.

Authors:  Ludmila Alekseeva; Nadezhda Mironova
Journal:  Int J Mol Sci       Date:  2021-11-12       Impact factor: 5.923

8.  Cancer progression mediated by horizontal gene transfer in an in vivo model.

Authors:  Catalina Trejo-Becerril; Enrique Pérez-Cárdenas; Lucía Taja-Chayeb; Philippe Anker; Roberto Herrera-Goepfert; Luis A Medina-Velázquez; Alfredo Hidalgo-Miranda; Delia Pérez-Montiel; Alma Chávez-Blanco; Judith Cruz-Velázquez; José Díaz-Chávez; Miguel Gaxiola; Alfonso Dueñas-González
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240

9.  Characterization of genomic clones by targeted deep sequencing of ctDNA to monitor liver cancer.

Authors:  Yan Sun; Xiaoyu Kong; Jing Yu; Xiaolin Zheng; Mufei Lin; Zhengyu Cheng; Hui Wang; Na An; Ying Xie; Shuang Zeng; Siming Xue; Min Xia; Xia Wei; Lijie Song; Fengxia Liu; Chunna Fan; Zhonghai Fang; Liangjun Gao; Yun Yang; Shida Zhu; Taiping Shi
Journal:  Transl Cancer Res       Date:  2021-10       Impact factor: 1.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.